Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Ceftriaxone products are in shortage in Canada (1 of 15 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A cephalosporin antibiotic given by injection to treat serious bacterial infections.
Products affected
1 / 15
Reports on file
42
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
CEFTRIAXONE FOR INJECTION
100G · POWDER FOR SOLUTION · FRESENIUS KABI CANADA LTD
DIN 02409968 · since ?, est. end Jun 15, 2026
Resolved
CEFTRIAXONE SODIUM FOR INJECTION BP
2G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02292289 · ended Apr 20, 2026 · Disruption of the manufacture of the drug.
Resolved
CEFTRIAXONE SODIUM FOR INJECTION BP
10G · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02292297 · ended Apr 20, 2026 · Demand increase for the drug.
Resolved
CEFTRIAXONE INJECTION, USP
2000MG · SOLUTION · BAXTER CORPORATION
DIN 02499738 · ended Feb 20, 2026 · Delay in shipping of the drug.
To be discontinued
CEFTRIAXONE SODIUM FOR INJECTION BP
250MG · POWDER FOR SOLUTION · STERIMAX INC
DIN 02325594
Discontinued
CEFTRIAXONE SODIUM FOR INJECTION
10G · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02287668
Discontinued
CEFTRIAXONE SODIUM FOR INJECTION
1G · POWDER FOR SOLUTION · TEVA CANADA LIMITED
DIN 02287633
Resolved
CEFTRIAXONE INJECTION, USP
2000MG · SOLUTION · BAXTER CORPORATION
DIN 02499738 · ended Jan 31, 2025 · Disruption of the manufacture of the drug.
Resolved
CEFTRIAXONE SODIUM FOR INJECTION BP
1G · POWDER FOR SOLUTION · STERIMAX INC
DIN 02325616 · ended Dec 19, 2024 · Delay in shipping of the drug.
Resolved
CEFTRIAXONE SODIUM FOR INJECTION BP
2G · POWDER FOR SOLUTION · STERIMAX INC
DIN 02325624 · ended Dec 19, 2024 · Delay in shipping of the drug.
Resolved
CEFTRIAXONE INJECTION, USP
1000MG · SOLUTION · BAXTER CORPORATION
DIN 02499711 · ended Aug 23, 2024 · Shortage of an inactive ingredient or component.
Resolved
CEFTRIAXONE SODIUM FOR INJECTION BP
250MG · POWDER FOR SOLUTION · SANDOZ CANADA INCORPORATED
DIN 02292262 · ended Jan 8, 2024 · Demand increase for the drug.
Showing 12 of 42 reports. All reports are on file with Health Canada.
What's happening
Ceftriaxone is currently affected by an active shortage report filed with Health Canada by FRESENIUS KABI CANADA LTD.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Ceftriaxone is classified under “OTHER BETA-LACTAM ANTIBACTERIALS” (ATC J01DD).
Recent changes
No changes recorded yet.
Common questions
What is Ceftriaxone used for?
A cephalosporin antibiotic given by injection to treat serious bacterial infections.
When will Ceftriaxone be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Ceftriaxone in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.